Abstract: An apparatus that acts as a shield for radiopharmaceuticals and protects individuals from radioactivity includes a first body with a first hollow core, a second body with a second hollow core and a third body with a third hollow core. The first hollow core, second hollow core and third hollow core collectively house an insert. The insert houses a hypodermic syringe. A first connection means releasably communicates the first body with the second body. A second connection means releasably communicates the first body with the third body. The second body comprises a piston actuator. The piston actuator can be operated to depress the piston of the hypodermic syringe while the first body is in communication with the second body, and while the third body is removed.

Abstract: An article of manufacture includes a first pad of sheets with a plurality of layers where the first pad of sheets perimeter is defined by a first edge, a second edge, a third edge and a fourth edge. The article of manufacture further includes a second pad of sheets with a plurality of layers where the second pad of sheets perimeter is defined by a fifth edge, a sixth edge, a seventh edge and an eighth edge. The first and second pad of sheets are releasably bonded together at the first edge of the first pad of sheets and at the fifth edge of the second pad of sheets by a first adhesive. The first adhesive forms a hinge structure allowing the first pad of sheets and second pad of sheets to rotate about an axis. The second pad of sheets are releasably bonded together at a portion of the bottom side of each layer of the second pad of sheets located at the fifth edge by a second adhesive. The remaining portion of the bottom side of each layer of the second pad of sheets is free of the second adhesive.

Abstract: Polypeptides comprising amino acid sequences of particulate antigens isolated from various species of Leishmania protozoa, or immunogenic variants thereof, are disclosed for the treatment and clinical remission of psoriasis. Also disclosed are nucleic acid sequences encoding such polypeptides, vectors incorporating such nucleic acid sequences, methods for genetically engineering microbial host cells to produce such polypeptides, and such recombinant microbial host cells. In another embodiment, immunotherapeutic agents incorporating the polypeptides or the nucleic acid sequences are disclosed for the treatment and clinical remission of psoriasis. In another embodiment, methods for the production of the polypeptides using recombinant microbial host cells are disclosed. Finally, methods for the treatment and clinical remission of psoriasis comprising administration of a pharmaceutical composition comprising one or more of the polypeptides or one or more of the nucleic acid sequences are disclosed.